Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Researcher: Blanket Approach to Asthma not Ideal

October 7, 2015 3:12 pm | by University of Queensland | News | Comments

University of Queensland research into the effects of dust mite and cockroach allergens has found that different types of asthma respond differently to a new experimental treatment. Read more...


U.N.: No New Ebola Cases Reported Last Week

October 7, 2015 3:11 pm | by The Associated Press | News | Comments

The first time an entire week has passed without any new confirmed patients since the devastating outbreak began last March. Read more...


Genetic Defences of Bacteria Don’t Aid Antibiotic Resistance

October 7, 2015 1:04 pm | by University of Oxford | News | Comments

Genetic responses to the stresses caused by antibiotics don’t help bacteria to evolve a resistance to the medications, according to a new study by Oxford University researchers. Read more...


Treating 5 Percent of Hepatitis C Patients with New Drugs Would Reduce Cost, Infections: Study

October 7, 2015 10:25 am | by University of Southern California | News | Comments

Treating 5 percent of all hepatitis C patients with the latest drugs would be more effective at reducing infections and health care costs than the current approach, a new study shows. The cost-benefits analysis by researchers compares three treatment options to the current approach, or "baseline" scenario, which treats patients in the most advanced stages of the disease when they may need a costly liver transplant. Read more..


Express Scripts to Provide Coverage for Praluent, Repatha

October 7, 2015 10:25 am | by Ryan Bushey, Associate Editor | News | Comments

Both drugs are PCSK9 inhibitors.


Sanofi: Launch of Generic Version of Arava Tablets

October 7, 2015 10:01 am | News | Comments

Sanofi US announced today the availability of an authorized generic version of Arava®, Leflunomide tablets through Winthrop, the company's US generics division. Read more...


Virus-drug Combination Shows Improved Effectiveness Against Brain Tumor Cells

October 7, 2015 9:57 am | by University of Florida | News | Comments

A rabbit virus currently being developed for cancer therapy can be paired with one of several existing drugs to deliver a more potent punch to a deadly type of brain tumor cell, researchers have found. Read more...

Smoking Cessation Drug Proves Initially More Effective for Women

October 7, 2015 9:53 am | by Yale University | News | Comments

The most effective prescription drug used to quit smoking initially helps women more than men, according to a Yale School of Medicine study. The study, published Oct. 7 by the journal Nicotine and Tobacco Research, found that varenicline, marketed as Chantix, was more effective earlier in women, and equally effective in women and men after one year. Read more...


Snapshot Turns T-Cell Immunology on its Head

October 7, 2015 8:15 am | by Monash University | News | Comments

Individuals with type 1 diabetes are thought to have a reduced number of the peacekeeping cells. Read more...


At a Glance: U.S. Trade Pact with Pacific Rim Countries

October 7, 2015 8:00 am | by The Associated Press | News | Comments

A key source of controversy stemmed from drug companies' efforts to protect their patents. Read more...


Oncolytics Concludes Enrollment for Phase 2 Prostate Cancer Study

October 7, 2015 7:45 am | News | Comments

Approximately 40 response evaluable patients were enrolled in each arm. Read more...


FDA Approves Aristada for Treatment of Schizophrenia

October 7, 2015 7:30 am | News | Comments

Alkermes is preparing to launch ARISTADA immediately.


Tolerant Immune System Increases Cancer Risk

October 7, 2015 7:15 am | by German Cancer Research Center | News | Comments

The scientists do not yet know why immune tolerance has an effect on certain cancer risks. Read more...


American Placebo

October 7, 2015 7:00 am | by McGill University | News | Comments

A new study finds that rising placebo responses may play a part in the increasingly high failure rate for clinical trials of drugs designed to control chronic pain caused by nerve damage. Read more...


New Test Predicts Teens’ Future Risk of Heart Disease

October 6, 2015 12:18 pm | by UVA Health System | News | Comments

Risk for cardiovascular disease, currently running rampant in the United States, can now be predicted for adolescents thanks to a new diagnostic test developed by a University of Virginia Children’s Hospital pediatrician and his collaborators. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.